15250-m-cuypers

61 HRQoL changes prior to Pca treatment onset 3 28. Rammstedt B, John OP. Measuring personality in one minute or less: A 10-item short version of the Big Five Inventory in English and German. J Res Pers. 2007;41(1):203-12. 29. Rammstedt B, Beierlein C. Can’t We Make It Any Shorter? Journal of Individual Differences. 2014;35(4):212-20. 30. Glaesmer H, Rief W, Martin A, Mewes R, Brähler E, Zenger M, et al. Psychometric properties and population-based norms of the Life Orientation Test Revised (LOT-R). British Journal of Health Psychology. 2012;17(2):432-45. 31. Ten Klooster P, Weekers A, Eggelmeijer F, VanWoerkom J, Drossaert C, Taal E, et al. Optimisme en/of pessimisme: factorstructuur van de Nederlandse Life Orientation Test-Revised. Psychologie en Gezondheid. 2010;38(2):89-100. 32. O'Connor AM. User Manual - Decision Self-Efficacy Scale Ottawa: Ottawa Hospital Research Institute (OHIR); 2002. Available from: https://decisionaid.ohri.ca/docs/develop/User_ Manuals/UM_Decision_SelfEfficacy.pdf. 33. van den Bergh RCN, Ahmed HU, Bangma CH, Cooperberg MR, Villers A, Parker CC. Novel Tools to Improve Patient Selection and Monitoring on Active Surveillance for Low-risk Prostate Cancer: A Systematic Review. European Urology. 2014;65(6):1023-31. 34. Festinger L. A theory of cognitive dissonance. Stanford, California: Univer. Press; 1957. 35. Sprangers MAG, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Social Science & Medicine. 1999;48(11):1507-15. 36. Gruppen LD, Margolin J, Wisdom K, Grum CM. Outcome bias and cognitive dissonance in evaluating treatment decisions. Academic Medicine. 1994;69(10):S57-9. 37. Nomura T, Fukuda Y, Sakamoto S, Nasu N, Tasaki Y. Comprehensive Evaluation of the Health- Related Quality of Life after Ultrasound-Guided Prostate Needle Biopsy: A Prospective Study. Andrology (Los Angel). 2016;5(160):2167-0250.1000160. 38. Mróz LW, Oliffe JL, Davison BJ. Masculinities and patient perspectives of communication about active surveillance for prostate cancer. Health Psychology. 2013;32(1):83-90. 39. Hoyt MA, Stanton AL, Irwin MR, Thomas KS. Cancer-related masculine threat, emotional approach coping, and physical functioning following treatment for prostate cancer. Health Psychology. 2013;32(1):66-74. 40. Holmes DS. Compensation for ego threat: Two experiments. Journal of Personality and Social Psychology. 1971;18(2):234-7. 41. Babl JD. Compensatory masculine responding as a function of sex role. Journal of Consulting and Clinical Psychology. 1979;47(2):252-7. 42. OromH, Nelson CJ, UnderwoodW, HomishDL, Kapoor DA. Factors associatedwith emotional distress in newly diagnosed prostate cancer patients. Psycho-Oncology. 2015;24(11):1416- 22. 43. Orom H, Biddle C, Underwood W, Nelson CJ, Homish DL. What Is a “Good” Treatment Decision? Decisional Control, Knowledge, Treatment Decision Making, and Quality of Life in Men with Clinically Localized Prostate Cancer. Medical Decision Making. 2016;36(6):714-25.